phosphagenics ltd (POH) Snapshot

phosphagenics ltd (POH) Details

Phosphagenics Limited, a biotechnology company, engages in the production, sale, and licensing of products for the cosmeceutical, nutraceutical and pharmaceutical, and animal health industries. It is involved in the commercialization of drug delivery applications based on its transdermal Targeted Penetration Matrix (TPM) technology that is used to deliver pharmaceutical and nutraceutical products. The company’s TPM delivery systems comprises vesicular systems; micro-emulsions; liquids, oils, gels, or creams; and patch systems. Its Nutraceuticals segment engages in developing active ingredients for various markets, including human and animal dietary supplements; functional foods and beverages; and personal care products under the Elixia and BioElixia brands through retail outlets. The company’s Pharmaceutical segment focuses on enhancing the delivery of existing drugs orally or through the skin utilizing its targeted penetration matrix technology. This segment’s products in clinical trials include an insulin patch for diabetics; an oxycodone patch for the relief of chronic pain; Lidocaine, a topical local anaesthetic used for a range of ailments, including temporary relief of rashes, stings, sprains, strains, bites, and burns; Diclofenac, a non steroidal anti-inflammatory drug used for sprains and strains; Tretinoin, the topical treatment of choice for acne; and Oxymorphone for pain indications. Phosphagenics Limited serves various customers in Australia, the United States, and internationally. The company was formerly known as Vital Capital Limited and changed its name to Phosphagenics Limited in 2004. Phosphagenics Limited is headquartered in Clayton, Australia.

phosphagenics ltd (POH) Top Compensated Officers